|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| License revenues and royalties | |||||
| Revenue, net | |||||
| Product revenues, net | |||||
| License revenues and royalties | |||||
| Total revenue, net | |||||
| Operating expense | |||||
| Cost of product sales | |||||
| Research and development | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Restructuring, impairment and other related costs | |||||
| Total operating expense | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Interest income | |||||
| Loss on debt extinguishment | |||||
| Interest expense | |||||
| Other, net | |||||
| Total other expense, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Loss before equity in net losses of joint venture | |||||
| Equity in net losses of joint venture | |||||
| Net loss | |||||
| Net loss per share | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Weighted average shares outstanding, basic (in shares) | |||||
| Weighted average shares outstanding, diluted (in shares) | |||||
Loading...